Skip to main content
Figure 2 | Trials

Figure 2

From: Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials

Figure 2

Evaluation design of the multidisciplinary cancer (MDC) team’s pre-screening decisions. Step one: extraction of the MDC reports from the oncologic electronic health records (her); step two: Extraction of the MDC team’s pre-screening decisions from the oncologic EHR; Step 3: systematic review of the MDC reports by the clinical research assistant (CRA); step four: comparison of the pre-screening decisions made by the CRA and the MDC team; step five: principal investigator’s review of the MDC reports corresponding to the discrepancies between the CRA’s decisions and the MDC team’s decisions; step six: final pre-screening decisions (gold standard) including the principal investigator’s decisions.

Back to article page